universal donor cell-based retinal pigmental epithelial cell therapy (Astellas)

N/A

Report date: 2025/01/26 15:55:02

Base Information

Drug Nameuniversal donor cell-based retinal pigmental epithelial cell therapy (Astellas)
Drug Alias NamerAAV genetically modified allogeneic cell therapy (Astellas/Universal Cells)universal donor cell-based retinal pigment epithelial cells (Astellas)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Retinal stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinal Diseases +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversal Cells Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc
Inactive CompaniesUniversal Cells Inc
Active IndicationsRetinal Diseases
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A